Home/Filings/4/0001209191-22-061908
4//SEC Filing

Grais Linda 4

Accession 0001209191-22-061908

CIK 0000907654other

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 4:24 PM ET

Size

9.1 KB

Accession

0001209191-22-061908

Insider Transaction Report

Form 4
Period: 2022-12-15
Transactions
  • Award

    Stock Option (right to buy)

    2022-12-15+6,0006,000 total
    Exercise: $2.32Exp: 2032-12-15Common Stock (6,000 underlying)
Footnotes (1)
  • [F1]Grant to the Reporting Person of a stock option under the 2020 Equity Incentive Plan, vesting in 12 equal monthly installments beginning as of December 15, 2022. If the Reporting Person's service as a director of the Issuer terminates in connection with or at any time following a change in control (for whatever reason), then any unexpired options that remain unvested shall become fully vested.

Issuer

ARCA biopharma, Inc.

CIK 0000907654

Entity typeother

Related Parties

1
  • filerCIK 0001413306

Filing Metadata

Form type
4
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:24 PM ET
Size
9.1 KB